Skip to main content
. 2020 Jul 21;28(11):2488–2502. doi: 10.1016/j.ymthe.2020.07.019

Figure 9.

Figure 9

A Scheme of the Proposed Mechanisms

Trastuzumab treatment increases the H3K27ac enrichment at the ZNF649-AS1 promoter region, inducing upregulation of ZNF649-AS1, which thereby increases ATG5 expression by guiding PTBP1 to activate its transcription. Then, increased ATG5 protein induced autophagy and trastuzumab resistance.